Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127200651 | 12720065 | 1 | I | 20160902 | 20160907 | 20160907 | EXP | GB-VIIV HEALTHCARE LIMITED-GB2016GSK128525 | VIIV | 0.00 | M | Y | 0.00000 | 20160907 | OT | GB | GB |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127200651 | 12720065 | 1 | PS | Celsentri | MARAVIROC | 1 | U | 22128 | |||||||||||
| 127200651 | 12720065 | 2 | SS | COTRIMOXAZOLE | SULFAMETHOXAZOLETRIMETHOPRIM | 1 | U | 0 | TABLET | ||||||||||
| 127200651 | 12720065 | 3 | SS | Dolutegravir | DOLUTEGRAVIR | 1 | U | 0 | FILM-COATED TABLET | ||||||||||
| 127200651 | 12720065 | 4 | SS | NORVIR | RITONAVIR | 1 | 100 MG, UNK | U | 0 | 100 | MG | ||||||||
| 127200651 | 12720065 | 5 | SS | PREZISTA | DARUNAVIR ETHANOLATE | 1 | 800 MG, UNK | U | 0 | 800 | MG |
Indications of drugs used
| no results found |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127200651 | 12720065 | OT |
| 127200651 | 12720065 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127200651 | 12720065 | Neoplasm malignant |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |